Avadel Pharmaceuticals Announces Journal of Urology Publication of Phase 3 Data on NOCTIVA Pharmaceutical Investing
Intra-Cellular Therapies Completes Submission of New Drug Application for Lumateperone for Treatment of Schizophrenia Pharmaceutical Investing
Rhythm Pharmaceuticals Announces Launch of TEMPO Registry for Rare Genetic Disorders of Obesity Pharmaceutical Investing
Biocure CEO: Our CAR-T Biosimilar Technology is Helping Terminal Leukemia Patients Recover Biotech Investing
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce the DEA has Rescheduled EPIDIOLEX (cannabidiol) Oral Solution to Schedule V Life Science Investing
DiaMedica Therapeutics and Ahon Pharma Announces Signing of License Agreement for DM199 in China for Acute Ischemic Stroke Pharmaceutical Investing
Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET (Avatrombopag) Pharmaceutical Investing
Zosano Pharma Enters Into Capital Equipment Lease Agreement With Trinity Capital Investment Pharmaceutical Investing
